EFFICACY OF COMBINED MODALITY TREATMENT INCLUDING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER
Short-and long-term results of combined modality treatment including neoadjuvant chemotherapy were analyzed in patients with stage II-III esophageal cancer. Group I patients (n=18) received 2 courses of combined gemzar/cisplatin chemotherapy followed by radical surgery. The control group patients (n...
Main Authors: | Yu. V. Rudyk, S. G. Afanasyev, S. A. Tuzikov, A. Yu. Dobrodeev, E. N. Samtsov, I. G. Frolova, I. G. Savelyev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
Series: | Sibirskij Onkologičeskij Žurnal |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/164 |
Similar Items
-
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer
by: Nicola Simoni, et al.
Published: (2020-12-01) -
The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
by: Yanan Lu, et al.
Published: (2019-10-01) -
Neoadjuvant Chemotherapy in Esophageal Cancer: Single Institution Experience
by: Shaffi Shaikh, et al.
Published: (2011-10-01) -
Major pathological response after neoadjuvant immunotherapy in esophageal spindle cell carcinoma: A case report
by: Yang Fu, et al.
Published: (2021-04-01) -
Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy
by: Lieven Depypere, et al.
Published: (2019-05-01)